论文部分内容阅读
背景:在公布临床试验的良好效果后,心血管疾病新治疗的采用率已有研究,但在药物研究的不良结果公布后对该药物的弃用率却知之甚少。
Background. The availability of new treatments for cardiovascular disease has been studied after the good results of clinical trials have been published, but little is known about the rate of abandonment of the drug following the publication of its adverse outcomes.